63 related articles for article (PubMed ID: 31372821)
1. FGF21 and glycemic control in patients with T1D.
Rosell Rask S; Krarup Hansen T; Bjerre M
Endocrine; 2019 Sep; 65(3):550-557. PubMed ID: 31372821
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 and calcium-phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes.
Vermeulen S; Scheffer-Rath MEA; Besouw MTP; van der Vaart A; de Borst MH; Boot AM
J Diabetes; 2024 Jun; 16(6):e13500. PubMed ID: 38124483
[TBL] [Abstract][Full Text] [Related]
3. Metformin Improves the Prerequisites for FGF21 Signaling in Patients With Type 2 Diabetes.
Pedersen AKN; Gormsen LC; Nielsen S; Jessen N; Bjerre M
J Clin Endocrinol Metab; 2024 Jan; 109(2):e552-e561. PubMed ID: 37776319
[TBL] [Abstract][Full Text] [Related]
4. Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
Richter MM; Kemp IM; Heebøll S; Winther-Sørensen M; Kjeldsen SAS; Jensen NJ; Nybing JD; Linden FH; Høgh-Schmidt E; Boesen MP; Madsbad S; Schiødt FV; Nørgaard K; Schmidt S; Gluud LL; Haugaard SB; Holst JJ; Nielsen S; Rungby J; Wewer Albrechtsen NJ
Metabolism; 2024 Jul; 156():155915. PubMed ID: 38631460
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation.
Tillmanns J; Weiglein JM; Neuser J; Fraccarollo D; Galuppo P; König T; Diekmann J; Ross T; Bengel FM; Bauersachs J; Derlin T
Int J Cardiol; 2024 Jul; 406():132044. PubMed ID: 38614364
[TBL] [Abstract][Full Text] [Related]
6. Association between Antioxidant Enzyme Activities and Enterovirus-Infected Type 1 Diabetic Children.
Abdel-Moneim A; El-Senousy WM; Abdel-Latif M; Khalil RG
Med Princ Pract; 2018; 27(1):86-91. PubMed ID: 29320773
[TBL] [Abstract][Full Text] [Related]
7. Neurophysiological Evidence for a Compensatory Activity during a Simple Oddball Task in Adolescents with Type 1 Diabetes Mellitus.
Vitvarová T; Neumann D; Šimáková R; Kremláček J
J Diabetes Res; 2018; 2018():8105407. PubMed ID: 30116745
[TBL] [Abstract][Full Text] [Related]
8. Study of FGF21 Levels in Transgender People and its Association with Metabolic Parameters.
Kumbar L; Kiran BH; Dharmalingam M; Kalra P
Indian J Endocrinol Metab; 2023; 27(4):330-334. PubMed ID: 37867987
[TBL] [Abstract][Full Text] [Related]
9. Pathological mechanisms of type 1 diabetes in children: investigation of the exosomal protein expression profile.
Bai B; Gao K; Zhang K; Liu L; Chen X; Zhang Q
Front Endocrinol (Lausanne); 2023; 14():1271929. PubMed ID: 37886648
[TBL] [Abstract][Full Text] [Related]
10. Effect of type 2 diabetes on the inducible degrader of LDL receptor.
Lam S; Lui DTW; Shiu SWM; Wong Y; Tan KCB
J Lipid Res; 2023 Jun; 64(6):100380. PubMed ID: 37094639
[TBL] [Abstract][Full Text] [Related]
11. Association of metabolic syndrome with serum fibroblast growth factor 21 in kidney transplanted patients.
Bagheri L; Hami M; Mojahedi MJ; Ghorban Sabbagh M; Ayatollahi H
J Renal Inj Prev; 2016; 5(2):79-84. PubMed ID: 27471739
[TBL] [Abstract][Full Text] [Related]
12. Women Have Greater Endothelin-B Receptor Function and Lower Mitochondrial Capacity Compared to Men With Type 1 Diabetes.
Derella CC; Thomas J; Harris RA
J Clin Endocrinol Metab; 2023 Sep; 108(10):2561-2568. PubMed ID: 37009678
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics analysis of serum and urine in type 1 diabetes patients with different time in range derived from continuous glucose monitoring.
Ma L; Liu J; Deng M; Zhou L; Zhang Q; Xiao X
Diabetol Metab Syndr; 2024 Jan; 16(1):21. PubMed ID: 38238828
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C as an adjunct to HbA1c may prove useful in predicting the development of diabetic complications in children and adolescents with type 1 diabetes.
Nilsson C; Dereke J
J Diabetes Metab Disord; 2024 Jun; 23(1):1251-1257. PubMed ID: 38932813
[TBL] [Abstract][Full Text] [Related]
15. Factors Influencing the Control of Diabetes Measured via Glycated Hemoglobin Concentrations in Adults with Type 1 Diabetes.
Sińska BI; Rzońca E; Kucharska A; Gałązkowski R; Traczyk I; Rzońca P
Eur J Investig Health Psychol Educ; 2023 Sep; 13(10):2035-2045. PubMed ID: 37887145
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity.
van Baak MA; Vink RG; Roumans NJT; Cheng CC; Adams AC; Mariman ECM
Int J Obes (Lond); 2020 Feb; 44(2):544-547. PubMed ID: 31455871
[TBL] [Abstract][Full Text] [Related]
17. Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications.
Tantawy N; Sherif E; Matter RM; Salah N; Abozeid NE; Atif H
Pediatr Endocrinol Diabetes Metab; 2023; 29(2):64-74. PubMed ID: 37728457
[TBL] [Abstract][Full Text] [Related]
18. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement.
Wan XX; Zhang DY; Khan MA; Zheng SY; Hu XM; Zhang Q; Yang RH; Xiong K
Front Endocrinol (Lausanne); 2022; 13():859638. PubMed ID: 35370989
[TBL] [Abstract][Full Text] [Related]
19. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
Taniguchi H; Nirengi S; Ishihara K; Sakane N
PLoS One; 2022; 17(2):e0263774. PubMed ID: 35192641
[TBL] [Abstract][Full Text] [Related]
20. Novel Adipokines CTRP1, CTRP9, and FGF21 in Pediatric Type 1 and Type 2 Diabetes: A Cross-Sectional Analysis.
Arking A; Sarver DC; Magge SN; Wong GW; Wolf RM
Horm Res Paediatr; 2022; 95(1):43-50. PubMed ID: 35172300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
